TScan Therapeutics
TCRX
TCRX
24 hedge funds and large institutions have $30.4M invested in TScan Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 7 closing their positions.
Holders
24
Holders Change
-1
Holders Change %
-4%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
7
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BBA
1
Baker Bros. Advisors
New York
|
$8.76M |
| 2 |
TCM
2
Tang Capital Management
San Diego,
California
|
$2.35M |
| 3 |
NM
3
Newtyn Management
New York
|
$782K |
| 4 |
4
Morgan Stanley
New York
|
$180K |
| 5 |
5
LPL Financial
San Diego,
California
|
$50K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Barclays
London,
United Kingdom
| – | -$445K | -158,944 | Closed |
|
27
Norges Bank
Oslo,
Norway
| – | -$168K | -60,000 | Closed |
|
28
Renaissance Technologies
New York
| – | -$37K | -13,300 | Closed |
|
29
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3K | -1,000 | Closed |
|
30
JPMorgan Chase & Co
New York
| – | -$1K | -361 | Closed |
|